Janice P. Dutcher

21.1k total citations · 6 hit papers
272 papers, 14.7k citations indexed

About

Janice P. Dutcher is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Janice P. Dutcher has authored 272 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Pulmonary and Respiratory Medicine, 99 papers in Oncology and 85 papers in Molecular Biology. Recurrent topics in Janice P. Dutcher's work include Renal cell carcinoma treatment (93 papers), Cancer Genomics and Diagnostics (44 papers) and Renal and related cancers (40 papers). Janice P. Dutcher is often cited by papers focused on Renal cell carcinoma treatment (93 papers), Cancer Genomics and Diagnostics (44 papers) and Renal and related cancers (40 papers). Janice P. Dutcher collaborates with scholars based in United States, Canada and France. Janice P. Dutcher's co-authors include Michael B. Atkins, Peter H. Wiernik, Kim Margolin, Geoffrey R. Weiss, Walter M. Stadler, Richard I. Fisher, Mario Sznol, David Parkinson, Gary R. Hudes and Theodore F. Logan and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Janice P. Dutcher

270 papers receiving 14.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

1999 1.5k citations Michael B. Atkins, Janice P. Dutcher et al. Journal of Clinical Oncology profile →
Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

2004 742 citations Michael B. Atkins, Walter M. Stadler et al. Journal of Clinical Oncology profile →
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

2008 707 citations Walter M. Stadler, Janice P. Dutcher et al. Journal of Clinical Oncology profile →
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

1997 684 citations Michael B. Atkins, Jeffrey A. Sosman et al. PubMed profile →
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

2004 598 citations David F. McDermott, Joseph I. Clark et al. Journal of Clinical Oncology profile →
Phase I clinical and pharmacokinetic study of taxol.

1987 380 citations Peter H. Wiernik, Janice P. Dutcher et al. PubMed profile →

Peers

Countries citing papers authored by Janice P. Dutcher

Since Specialization

Citations

This map shows the geographic impact of Janice P. Dutcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice P. Dutcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice P. Dutcher more than expected).

Fields of papers citing papers by Janice P. Dutcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice P. Dutcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice P. Dutcher. The network helps show where Janice P. Dutcher may publish in the future.

Co-authorship network of co-authors of Janice P. Dutcher

This figure shows the co-authorship network connecting the top 25 collaborators of Janice P. Dutcher. A scholar is included among the top collaborators of Janice P. Dutcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice P. Dutcher. Janice P. Dutcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805) 2021 ·Clinical Cancer Research ·Wenxin Xu, Mäneka Puligandla, Brian Halbert, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Venkata Sabbisetti, Rupal S. Bhatt	26
2	Long-Term Progression-Free Survival of Patients with Metastatic Melanoma or Renal Cell Carcinoma following High-Dose Interleukin-2 2021 ·Journal of Investigative Medicine ·Joseph I. Clark, Brendan D. Curti, Elizabeth J. Davis, Howard L. Kaufman, Asim Amin, Ajjai Alva, Theodore F. Logan, Ralph J. Hauke, (unknown), Ulka N. Vaishampayan, Douglas B. Johnson, Richard L. White, Peter H. Wiernik, Janice P. Dutcher	15
3	Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma 2019 ·Clinical Cancer Research ·Wenxin Xu, Mäneka Puligandla, Judith Manola, Andrea J. Bullock, Daniel Tamasauskas, David F. McDermott, Michael B. Atkins, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Rupal S. Bhatt	11
4	Renal cell carcinoma in patients with a personal or family history of hematologic malignancies. 2015 ·PubMed ·Janice P. Dutcher, Peter H. Wiernik	5
5	Report of a Phase I Evaluation of Dose and Schedule of Interleukin-1 Alpha and Cyclophosphamide in Patients with Advanced Tumors: An Eastern Cooperative Oncology Group Study (PX990) and Review of IL-1-Based Studies of Hematopoietic Reconstitution 2014 ·Journal of Interferon & Cytokine Research ·Janice P. Dutcher, Donna Neuberg, Michael B. Atkins, William Tester, Scott Wadler, James A. Stewart, Abraham Chachoua, Lynn M. Schuchter	3
6	Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group 2011 ·Clinical Cancer Research ·Judith Manola, Patrick Royston, Paul Elson, (unknown), Madhu Mazumdar, Sylvie Négrier, Bernard Escudier, Tim Eisen, Janice P. Dutcher, Michael B. Atkins, Daniel Yick Chin Heng, Toni K. Choueiri, Robert J. Motzer, Ronald M. Bukowski	148
7	Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus 2011 ·Journal of Clinical Oncology ·Pablo Maroto, Gary R. Hudes, Janice P. Dutcher, Theodore F. Logan, Charles S. White, Mizue Krygowski, Maria Cincotta, Mark Shapiro, Ignacio Durán, Anna Berkenblit	83
8	Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program 2010 ·Oncology ·Ronald M. Bukowski, Walter M. Stadler, David F. McDermott, Janice P. Dutcher, Jennifer J. Knox, Wilson H. Miller, John D. Hainsworth, Charles Henderson, Julio Hajdenberg, Tamila L. Kindwall‐Keller, Marc S. Ernstoff, Harry A. Drabkin, Brendan D. Curti, Luis Chu, Christopher W. Ryan, Sébastien J. Hotte, Chenghua Xia, Lisa Cupit, Robert A. Figlin	33
9	Phase I/II Trial of Outpatient PEG-interferon With Interleukin-2 in Advanced Renal Cell Carcinoma: A Cytokine Working Group Study 2007 ·Journal of Immunotherapy ·Joseph I. Clark, (unknown), Jeffrey A. Sosman, Theodore F. Logan, Kim Margolin, Janice P. Dutcher, Walter J. Urba, Marc S. Ernstoff, David F. McDermott, (unknown), Michael B. Atkins	4
10	Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: A study of the Eastern Cooperative Oncology Group (E1993) 2004 ·Leukemia & lymphoma ·Janice P. Dutcher, Sandra Lee, Robert J. Gallagher, Adel Makary, John Hines, (unknown), John P. Farnen, John M. Bennett, Elisabeth Paietta, Jacob M. Rowe, Olga Goloubeva, Peter H. Wiernik	7
11	Characterization of bone metastases in patients with renal cell cancer 2004 ·British Journal of Urology ·(unknown), Janice P. Dutcher, (unknown), Susan Garl, (unknown)	20
12	Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma 2004 ·Cancer ·David M. Nanus, (unknown), Matthew I. Milowsky, (unknown), Janice P. Dutcher	121
13	Therapeutic potential of curcumin in prostate cancer—IV: Interference with the osteomimetic properties of hormone refractory C4‐2B prostate cancer cells 2003 ·The Prostate ·Thambi Dorai, Janice P. Dutcher, David W. Dempster, Peter H. Wiernik	51
14	Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon 1998 ·Medical Oncology ·R. Katherine Alpaugh, (unknown), (unknown), Michael B. Atkins, Joseph A. Sparano, Lynn M. Schuchter, Louis M. Weiner, Janice P. Dutcher	19
15	Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-lbα with different functional properties 1997 ·Journal of Laboratory and Clinical Medicine ·Leslie Oleksowicz, Janice P. Dutcher, (unknown), (unknown), Polly R. Etkind	27
16	Overview by an oncologist: What are the imaging needs of the oncologist and oncological surgeon? 1997 ·Seminars in Nuclear Medicine ·Rasim Gucalp, Janice P. Dutcher, (unknown)	14
17	Atypical clonal T-cell proliferation in infectious mononucleosis 1996 ·Medical Oncology ·(unknown), Leslie Oleksowicz, Janice P. Dutcher, Peter H. Wiernik, Howard Ratech, Michael J. Borowitz	24
18	Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: Increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease 1994 ·Leukemia Research ·(unknown), Peter H. Wiernik, Nancy Sun, (unknown), Deborah Thompson, Steven Hallam, Xiao Hu, Janice P. Dutcher, Robert E. Gallagher	12
19	Modern transfusion therapy 1990 ·CRC Press eBooks ·Janice P. Dutcher	16
20	Successful Treatment of Hairy Cell Leukemia with 2ʼ-Deoxycoformycin After Failure of Interferons Alpha or Beta 1990 ·American Journal of Clinical Oncology ·Janice P. Dutcher, (unknown), Peter H. Wiernik	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact